Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 in PAOO for Malocclusion
NCT03396900Phase 2Completed
- Sponsor
- SVS Institute of Dental Sciences
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dibotermin alfa in malocclusion, sponsored by SVS Institute of Dental Sciences. Started Jul 2016; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
malocclusion
Beyond the preview
Go deeper on NCT03396900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396900.